Obstructive sleep apnea and hypertension

Current Hypertension Reports

Volumn 12, Issue 3, 2010, Pages 189-195

  Calhoun, David A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Continuous positive airway pressure; Hyperaldosteronism; Resistant hypertension; Sleep apnea

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

AIRWAY RESISTANCE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE RESISTANCE; DISEASE SEVERITY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME; STROKE;

BLOOD PRESSURE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT FAILURE; UNITED STATES;

EID: 77956392737     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0112-8     Document Type: Review

References (49)

1. Ohkubo T, Hozawa A, Nagai K, et al.: Prediction of stroke mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000, 18:847-854.
2. Dolan E, Stanton AV, Thom S, et al.: Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients-an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens 2009, 27:876-885.
3. Kario K, Pickering TG, Matsuo T, et al.: Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001, 38:852-857.
4. Ben-Dov IZ, Kark JD, Ben-Ishay D, et al.: Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007, 49:1235-1241.
5. Dolan E, Stanton A, Thijs L, et al.: Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005, 46:156-161.
6. Pedersen OL, Mancia G, Pickering T, et al.: Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipineperindopril treatment: a VALUE substudy. J Hypertens 2007, 25:707-712.
7. Salles G, Cardoso CRL, Muxfeldt ES: Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008, 168:2340-2346.
8. Cook NR, Cohen J, Hebert PR, et al.: Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995, 155:701-709.
9. Law MR, Morris JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:1245-1253.
10. Fletcher ED, DeBehnke RD, Lovoi MS, et al.: Undiagnosed sleep apnea in patients with resistant hypertension. Ann Intern Med 1985, 108:373-376.
11. Lavie P, Ben-Yosef R, Rubin AE: Prevalence of sleep apnea syndrome among patients with resistant hypertension. Am Heart J 1984, 108:373-376.
12. Worsnop CJ, Naughton MT, Barter CE, et al.: The prevalence of obstructive sleep apnea in hypertensives. Am J Crit Care Med 1998, 157:111-115.
13. Grunstein R, Wilcox I, Yang TS, et al.: Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1994, 17:533-540.
14. Grunstein RR, Stenlöf K, Hedner J, et al.: Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish obese subjects (SOS) study. Int J Obes Relat Metab Disord 1995, 19:410-408.
15. Lavie P, Herer P, Hoffstein V: Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. JAMA 2000, 283:1829-1836.
16. Young T, Peppard P, Palta M, et al.: Population-based study of sleep-disordered breathing as a risk factor for systemic hypertension. Arch Intern Med 1997, 157:1746-1752.
17. Hla KM, Young TB, Bidwell T, et al.: Sleep apnea and hypertension: a population-based study. Ann Intern Med 1994, 120:382-388.
18. Bixler EO, Vgontzas AN, Lin BK, et al.: Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160:2289-2295.
19. Durán J, Esnaola S, Román, et al.: Obstructive-sleep apneahypopnea and related clinical features in population-based sample of subjects aged 30-70 yr. Am J Respir Crit Care Med 2001, 163:685-689.
20. Nieto FJ, Young TP, Link BK, et al.: Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
21. Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
22. Brouwers FM, Lenders JW: Sleep-disordered breathing and hypertension. N Engl J Med 2000, 343:967.
23. O'Connor GT, Caffo B, Newman AB, et al.: Prospective study of the association between sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179:1159-1164.
24. Peppard PE: Is obstructive sleep apnea a risk factor for hypertension?- differences between the Wisconsin Sleep Cohort and the Sleep Heart Health Study. J Clin Sleep Med 2009, 5:404-405.
25. Durán-Cantolla J, Aizpuru F, Martínez-Null C, et al.: Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Med Rev 2009, 13:323-331.
26. Bazzano LA, Khan Z, Reynolds K, et al.: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
27. Alajmi M, Mulgrew AT, Fox J, et al.: Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67-72.
28. Mo L, He QY: Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials [in Chinese]. Zhonghua Yi Xue Za Zhi 2007, 87:1177-1180.
29. Haentjens P, Van Meerhaeghe A, Moscariello A, et al.: The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med 2007, 167:757-765.
30. Calhoun DA, Harding SM: Sleep and hypertension. Chest 2010, in press.
31. Somers VK, Dyken ME, Clary MP, et al.: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
32. Narkiewicz K, Kato M, Phillips BG, et al.: Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332-2335.
33. Iahida K, Kato M, Kato Y, et al.: Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 2009, 136:125-129.
34. de Lima AM, Franco CM, de Castrol CM, et al.: Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 2009 Jul 3 [Epub ahead of print].
35. Phillip CL, Williams A, Roth M, et al.: The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007, 16:217-225.
36. Drager LF, Bortolotto LA, Figueirdo AC, et al.: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
37. Kitahara Y, Hattori N, Yokoyama A, et al.: Effect of CPAP on brachial-ankle pulse wave velocity in patients with OSAHS: an open-labelled study. Respir Med 2006, 100:706-712.
38. Logan AG, Perlikowski SM, Mente A, et al.: High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001, 2271-2277.
39. Calhoun DA, Nishizaka MK, Zaman MA, et al.: Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004, 125:112-117.
40. Pratt-Ubunama MN, Nishzaka MK, Boedefeld RL, et al.: Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453-459. In demonstrating that severity of OSA is related to aldosterone levels in patients with resistant hypertension, this study implicates hyperaldosteronism as an important underlying cause of the high prevalence of OSA observed in patients with resistant hypertension.
41. Grote L, Hedner J, Peter JH: Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000, 18:679-685.
42. Lavie P, Hoffstein V: Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001, 24:721-725.
43. Elias RM, Casdtro MCM, de Queiroz EL, et al.: Obstructive sleep apnea in patients on conventional and short daily hemodialysis. Am J Nephrol 2009, 29:493-500.
44. Logan AG, Tkacova R, Perlikowski SM, et al.: Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21:241-247.
45. Chiu KL, Ryan CM, Shiota S, et al.: Fluid shift by lower body airway cross-sectional increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006, 174:1378-1383.
46. Bucca CB, Brussino L, Battisti A, et al.: Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007, 132:440-446.
47. Gaddam K, Pimenta E, Thomas SJ, et al.: Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2009 Dec 17 [Epub ahead of print].
48. Raff H, Roarty TP: Renin, ACTH, and aldosterone during acute hypercapnia and hypoxia in conscious rats. Am J Physiol 1988, 254:R431-R435.
49. Svatikova A, Olson LJ, Wolk R, et al.: Obstructive sleep apnea and aldosterone. Sleep 2009, 32:1589-1592.